Anaerobe bakterier og resistens. Ulrik Stenz Justesen Klinisk Mikrobiologisk Afdeling Odense Universitetshospital Odense, Denmark
|
|
- Lawrence Whitehead
- 6 years ago
- Views:
Transcription
1 Anaerobe bakterier og resistens Ulrik Stenz Justesen Klinisk Mikrobiologisk Afdeling Odense Universitetshospital Odense, Denmark
2 Programme anaerobic bacteria Carbapenem and metronidazole resistance New methods for detecting resistance, including MALDI-TOF (and WGS) supplemented with a few cases 2 the first mentometerfråga
3 The Danish situation
4 Carbapenem-resistance The most common type of carbapenem-resistance in anaerobes is metallo-betalactamase production in Bacteroides fragilis Metallo-betalactamases hydrolyses (break down) almost all betalactam antibiotics penicillins, cefalosporins and carbapenems 4
5 Carbapenem-resistance and the cfia gene cfia gene (chromosomal) encodes a metallo-betalactamase (MBL) in Bacteroides fragilis The degree of resistance is determined by IS (insertion sequences) elements, which serves as promotors for the cfia gene 5 Sóki et al. J Med Microbiol. 2004
6 Metronidazole mechanism of action Metronidalzole is reduced by ferredoxin to toxic metabolites (only in anaerobic cells) The toxic metabolites disrupts the DNA 6 Virkningsmekanisme
7 Metronidazole-resistance Rare, in otherwise susceptible species (Bacteroides, Prevotella, Clostridium) Resistance mechanism: nim genes (A-J) encodes a nitroimidazole reductase chromosomal or on a plasmid The nitroimidazole reductase converts metronidazole to non-toxic metabolites 7 The prescense of a nim gene is NOT equal to resistance and resistance is NOT equal to the prescense of a nim gene
8 Phenotypic tests the Gold standard Agar dilution for MICs Impossible in a routine laboratory 8
9 Phenotypic tests Screening with disk diffusion (some crazy labs)!!! Gradient strips (breakpoints according to EUCAST) Meropenem-EDTA or imipenem-edta doubble-etest demonstrate MBL (cfia mediated?) Bacteroides fragilis ATCC Bacteroides fragilis ATCC MBL+ Bacteroides fragilis
10 Pseudo metronidazole-resistance Clostridium perfringens DSM Metronidazole resistance in the laboratory is very often caused by insufficient anaerobic conditions Oxygen in the anaerobic atmosphere 10 Metronidazole is NOT reduced to toxic metabolites Justesen et al. Diagn Microbiol Infect Dis
11 The new methods for detecting resistance MALDI-TOF Whole genome sequencing (WGS) 11
12 Methods available for antimicrobial susceptibility testing with MALDI-TOF 1) Demonstrating a genotype = resistance (e.g. the meca gene) 2) Demonstrating break down of an antibiotic (e.g. hydrolysis by a beta-lactamase) 12 3) Demonstrating bacterial growth 4) Demonstrating bacterial kill
13 2) Demonstrating break down of an antibiotic MALDI-TOF hydrolysis assay Beta-lactam antibiotics, in this case carbapenems, are hydrolysed by the metallo-betalactamase encoded by the cfia gene in B. fragilis 13 Hydrolysis results in mass changes of beta-lactams, which can be measured by MALDI-TOF
14 MALDI-TOF hydrolysis assay Start here 14 Johansson et al. Anaerobe. 2014
15 MALDI-TOF hydrolyse assay Imipenem R > 8 mg/l Ertapenem R > 1 mg/l 15 Johansson et al. Anaerobe. 2014
16 Not quite there with MALDI-TOF yet! The presence of beta-lactam hydrolysis is not always equal to betalactam resistance in the presented examples with B. fragilis 16 We need more
17 3) & 4) Demonstrating bacterial growth/kill - with the MALDI BioTyper Antibiotic Susceptibility Test Rapid Assay MBT-ASTRA 17
18 Workflow MBT-ASTRA The boxes = variables Broth? McFarland ##? Antibiotic concentration ##? Incubation C (?) Species dependent ##? time Cell lysis Lysis reagent with internal standard (IS) 18 Target preparation Acquisition of MS profile spectra
19 Intensity Intensity Intensity Intensity MBT-ASTRA measuring the AUC SUSCEPTIBLE STRAIN RESISTANT STRAIN IS Bacteria IS Broth only IS Bacteria IS Mass Mass 19 IS Bacteria IS Broth + antibiotic IS Bacteria IS Mass Mass IS = internal standard
20 MBT-ASTRA and Bacteroides fragilis ATCC 25285* Results Broth only Metronidazole 4 mg/l 20 Metronidazole 8 mg/l Metronidazole 32 mg/l BB: Brucella broth MTZ: metronidazole *B. fragilis ATCC is fully suscpetible to metronidazole
21 MBT-ASTRA and Bacteroides fragilis Resistant and suscpetible can we detect a difference? Broth only Pip-tazobactam 128 mg/l Broth only 21 Pip-tazobactam 128 mg/l Resistant Susceptible BB: Brucella broth TZP: piperacillin-tazobactam
22 Still some work ahead Quantifying the level of resistance from the AUC Isolates close to the breakpoint will probably be a challenge! 22
23 A few cases with a little WGS 23
24 Case: Abscess with B. fragilis Akershus universitetssykehus HF MIC (mg/l) Meropenem: >256 Piperacillin-tazobactam >256 Clindamycin >32 Metronidazol >32 24 imipenem-edta og meropenem-edta doubble-etest POSITIVE (Ratio 8) Mechanisms?
25 WGS workflow for dummies 25 Sample on machine Data from machine
26 TGTCGCTTTCAGGTCACCAGTACCTGAACCTAAGGCCGGCACTTCGATAACAGCTTGATTGTAAGACAGCACATTTACCCCTTCCGTATATTTAGACTCCTGGTTGAAACCGGCCATTACGCTAAAATGGTGGTCTTTCTTAATATCAAACTTATATGTACCATAAATATTGAAGGCATTGTAATCGGTG AACTGTTTTTCTTTCTGCAAATAGTCTTTTGCAGCATTCCAGATGTTGTTACCTCCCTGTATGTCTGTATACTGAGTTTTTCCGGTATAGAAATTATAGTCATACATGTTTTTGTCAAACGTGTATTCAAATACCCCTTCAAAGCCTTTGAATGGCTTCAAAATAGATTTCACGAAAACACGCGGATTGTCAT ATGACTTTTTCCATTTATTCGCCAACAACACCTGATTACGCGGTGTATTGAAAGGCAAATCCTGAGAGATTGTAGAACAAACGTCCGCAGGCATATTACCTTCCGGTTGATAAGAAACCTGATTACTACCGAACATGCTTCCCAGACCGGAACTCGGTTGTGACTGATTGGTACGCGCATAGCTCATTG TCAGTTCCTGAGTAAACCATTTGGTAATATCAGCAGAAATATAAGAATTGATATTCAGACGTTCATACGTATCTTTATCGGTAATCAAAACACCGTCCGTAGATACATATCCGGCTGACATACGGTAACGCAACTTATCTGTACCGCCGGATACAGAAAGATTATGATTCATCTGGAAACTGGTCTCCAT AAAATTCTTATATGGATCATGTTCGTTCAGATAATACAAGGCTCCGTCCGTATCGGCAAAAATACCATCACCTACAGTTTTGATAGATGAAGGATCCTGCCTGTACTGTGTCAGGTATTCCTTCCATTTTGAAACACTGGGTGAACCATAAGACCAATAAGCATCAGAATATCCTCCATCCTGATAAGCC TGCAGGTAATCCATTAACGATGCTTGCTTCGGCAGATTCATTGCAGTAGCAAAACCGAAATTATTGTTATAGTTCAGGCGGAAAGCCGTAGCTTCTTTCGGGCGCTTAGTAGTCACCAAAACCACACCACCGGCCGCACGCGCACCATAAATAGCTGCCGAAGCAGCATCTTTCAGTACCGTCACCG TTTCGATATCTTCCGGATTCAACATGTCGAGGCTACCCTCTACGTTATCAATCAAGATAAGAGGCGCGACATTGGCACCATAGCTTCCGTCGCTATTCTTGATACCTACTGAATAGGCACCACGCAGTTGGAATGACTTTCCGCTACCCGGTGCATTCCCGCTATTAGATACCAGCAGTCCCGGAACC GTACCTTGCAATGCATCGGAAGCTGTCATAATAGGACGGTCCCCGATAATCTCATCCATTTTGATAGATGAAACAGCACCTGTCAAGTTTGCTTTCTTTTGTGAACCGAAACCGACTACCACTACTTCGTCTAAGGTACGAGAGTCATCTTTCAGCACTATCTTCAAAGGAACACCGGCCACGGCTTTC ACTTCTTGTGTTACATAACCGATATAAGAGATAACGATAACAGCACCCGGATTTACCGACAAAGAGAAATTTCCCTCTACATTACTGATCGTACCATTCTGGGCATTGTTTTTTTCCATAATGGTAGCACCAATAATCGATTCTCCCAGGTTATCCCTGATATTACCTTTTACAACGATCTTATTACTCTGC TGTGGTGTGGAAACTACCTCCGGAGCACTCTTCAGAATAACTTCATTGCCCTTGATGACATAGCTGATACCACTGTCTTTAAACAGCACATTCAGTACCTCCTCTATGGAGCCTTCACAATTGATGTCACGGATCTTTGCATTACCCAAATCGGCTGCCTTGTAAAAGAACGTATATTTACTGTTCTTTT CAATAACCTGGATGGCCTGTTTAATGCTCATTGCCTTTCCCTGCACGGCTATCTGTCCCTGCACGGCAAAAACGGACATAGGATACAGGAGCATAAACATAATTACGCCTGCCAGAAAACGCCTGTTACAGACGCTAAAACATTGTCTCATGTCTTTCATTTTTTTGATTATACGATTAATTAGTGATTG ATAAAAAAGCGATTATTTATAAATAATGATTCTCTGTGTTTCTTTTCTAAATTTCAAATTCATATTGATACAAATCTTTTCGATAACTTTAGATGCGGGGTCATCATAACGCATATAGCCTGTGAACAAGTCATTTCGGGATACTTTCTCGTCGAGCTCTACCGGAATATGGTAAATATCATGAATGGCTTCT ATCAAATCATCCATACGCATGTCGACAAATTTGTAACGTCCCTCATCCCAACTGATATTACCTATATTCTTTAATATCACTTCATCCTTTTCGGGATGAAAAATAATCTGTTGCAAAGGTTTCATTTCAATCTTCCTCTGCGAAGCCTTAGCGTTGAAATCAACCTTTCCACTAAAAAGAGTCACTTCCGCA CCATACTGCCGGGTGGACTGAACACGAAAAACCGTCCCTTTGACTTCTACAAATGCCTGATCAATATATACCTTAAAATTACGTCCCTTACGTTTGGTTACCTCAAAAGTAGACTCTCCCTCCAACCAGACTTCCCGTTTATCCATAAAGTCCTGTGAAAAACGGATTCGACTTCCGGCTTGCATCCAA ACCCTTGAACTGTCGGGGAGCACGTACAACCGGCTATTTGAAGAAACAATCTCAGTATACTCAATGATATGTTGCGAAGTGACAGGCTCCTCATTAAAAAAGAAGATACTTCCCCCAACAACCAATAACACTGTAATACATGCAGCGAGAGCAATCTTCAAGTACCTGAGCTGGAGCCGTTGCTTACG TTCAAAAGGAGTCTGACATTTGGAATCAATCTTATTCCAAATCCTACTTTCAACAGCAGCATCATCCACTATATTCCTTGCAGCATCAAATTGTTTTTTCATCTTTGTCTCCACAACATCCCAGTGCGCCAGCTCTTCTACTTCTCCCGGAGAAGACTTACCGGCAATCAATTTGCGGACAAGCCGATCG TATTTATTAGAAATCTTCATATTCTTTATATTTCTTTCCAAAAGCCCAAGCTATATTTATAAATCTATCCATAAATACACAATTTATAAAATTCCCCCCTATATGTTTTCCGCTTTTTTTCTGTTTTATAAATTGAGTATGCTATATTTGTAATCCAAACGTAACTCTTAATGAACGAAAAAGAAGCAATTATTAA ACTGAAGACCCGCAATGATAAAGCTGCCTTTGCATTCCTGTACCACTCTTATTGGGCTAAGGTTTACAACTTTACGCGACTTTATGTCACTTCTTTGGTTGATGTGGAGGAAATCGTTCAAGAGGTTTTTATTAAAATCTGGGAGAGCAGAGAGTCTTTGGATGAAGAGCAAAACTTTGCAGGATATCTG TTCATCACCATGCGTAACCTTGTTTTTAACCGCTCCCGCAAGAATCTGAACGAGGCTTTCTACCAACTGTCAGTGATAGAAGCAGTAGAAGAGTCATATGATATAGAAGAAGAACTGGATGCAGCCAATCTACGGACACATATCGAATCACTTATTTCAATGTTACCACCCCGGCAACAGGAAGTATTC CGTCTGAGCAGGGACGAAGAACTTTCTTATCGTGAAATTGCAGAGAAACTGCAAATATCGGAAAGAACAGTGGAACACCACATATCCGATGCTTTGAAGTTTCTAAGAAAAAACATCAAGCTTTACACATTATTCCTTTCATTATAAATGAAGTAGCGCTGCTCTTCCCCGTTGGGACAGAACAGCGCC GATCATCAGTTTTTTATGAAAAACGAAACTTTCTTTCATAGAGAGGTATTACACTTACATAACAATTCTCTCTTCACAGAGATACTATTAACACTATATATAAACATGATGATTTTCATTAATAAATCAAAAATAAACATTTCTATAAAAATAAGAAATGGAAATCGACTAATAGAACAATTTAATCGATCAAAA TGTTCTCTACATTTTCAGTAAACGTTTACTCAAATACCTTACCGGATACCAGACAGATAAAAATCCGACAGTAAATACGGTAATAAATATCACGATGACATCCCCCAAATGAACACTGACCGGATAGGAATCAACTACAAAATTACCTGCAGCATTACCTCCACCCAATGAAACTATCCCGTAGGCCATC TGAACCCAACATAGAACCAAGCCGAGTATAATCCCGATTATAGCCCCATAAAAGGAAATCATACATCCTTCGAAAAGGAAAATACGCGAAACAAGCCGATCGTCAGCTCCCAATTTACGAAGTGTATTCACATCTTCCTTTTTATCCAGAATAAGCATCGACAGCGAACCTATCACATTGAAACAGGCG ATCACGAGAATAAAGGTAAGAAACAAATACGAAACCAATTTCTCTATCTCCATGATGCGAAACACATCCTCCTGCTGCTCGTAACGGTTACGAATAACAAAACCATCTCCTAACGCCTTCCCGATCTTTTCTTTCACTACAGAAATATTAGATCCCGGCTTTAGTTTCAGTTCTATTGCAGACACTTCGGT AGTATAATCAAGCAAACGCCGGGCAAAATCCAACGAAGTGAGAATATACTGTCCGTCATACTTCTGCTGATTGACTACAAACACTACACCGGGCGAATACAAATAATCCATATTAAAGGAAGCAGCCGGATTTGCAAGATTAACCTTTCCATTCCTTTTAGGAATATATACCTGCAAAGGATCGACAAA CCTGATTCCGGTCCCCAATGTAGAGACAAGCTCAATCCCCATCACTCCATAATCCACAACAGAATCGTTCAACAAAAACTCACCTGCTCCATAAAGGATACTATCTATTGCAGTCAACTGCTCAAAATTATCTTGTACCCCCTTTATAACAGCCATTGTTTGACGATCCTTGTATTGCACCATCGCATTC TCTTCAAGTGTTTCAGTCAACACATCTACTTCCGGCATCTGCCGGATAGCCTGAATACGCGGGTCCTGTGCATCGAAAACTTTCCCTTCGGCAATCGTCACTTTCAGTTCCGGATCAAACACAGTAAACAGATCGGCTACTGTATCCTGAAAACCATTGAATACGGAAAGTGTACACACCATTGCCATC GTAGCCAATGCTACTCCACACACGGAAATAGCCGAAATGATATTAATGGCATTGTGTTTCTTCTTTGAGAAAAGATATCGCCGGGCTATGTAGAAGGGAAGATTCACTTCAACAAGGCATCTATCTTTTCAATGTAGTCCAGCGAATCGTCCACAAAAAATTTCAATTCGGGGATAATACGCAACTGAT GACGAACACGGGTACCGAGTTCGAAACGGATGGACTTCATATTATTATTGATATTCTTTACCATTTCTTCGCTTTTATCAGAAGGGAAGACACTTAAATATACGCGGGCAATGCTCATATCAGGGCTGATACGTACAGCACTGACAGATACCAACACACCGGGCATGGCCTTGGTCTGCAACAGAAAA ATCTCACTGAGTTCTTTCTGTAACAAACGGGCTATCTTATTCTGTCTCGTTGTTTCCATAAACTTTCTACGTAATTATTTTATCAAACAAGCAATTAGCACTTGTTACAATAGAACACAAAATTAGAGAAATATATCGTTTGACAGATAAAATATGTACTATTTTTAATCTTCATTATTGAATTATTCTTCCAAT GCTAAAGAGTAATCAACTAATACACATCTCACTTTTTACGAATAATGGTCAGTCCATCACGCAAAGGGAGGATTACTTTCTCCACTCGTTCATCATGTGCCACCAATTCGTTGAAAGCCTTAATACCGATGGTTTGATAGTCGTTGTTATGTGGCTCTTCCAGCACATGACCATCCCATAAAGTGTTATC GGCTATGATATATCCTCCGGGAGAAAGATGCGCAAGAGTCATCTCATAATATTCAATATACTTACGTTTATCGCCATCCACAAAAGCAAGGTCAAACGTAACTCCCAATGCAGGTATCAATTGGAGAGCATCTCCAATGTAGAATTTAATTTTATCAGCATAAGCTGAATTTTCGAGCCAGGGACGGGT AAAGTCTTCCTGTTCGTCATTTATCTCAAATGTGTGGAGCATTCCACCCTCCTCAAGTCCTTCGGCCAAGCAAAGGGCGGAATAGCCACTATAAGTTCCTATTTCTAATATCTGGCGAGGCCGTATCATACGAACAAACATCTTCAACATACGCCCCTGCAGATGACCGGAAGCCATACGGGGACGCA GAAGCTTGACATGCGTATCCCGATAAAGAGCTTTCAGGTATTCACCTTCTTCATCGATATGCTTTAGGATATATTCGTCTAAAAGATCGGTCTCTTTCATCTCATCCTACAGATAACGGTTGCTGTTAGGCAATACACTGTCACCGGCATGCTTCAAAGCATCTTCCACGACATTGATCTCAAGGAAAGA GGTTTGTGTCCCGGCTTTACCGCTACTCAGATAACCCACCATATCAGTAGGATGTAAACGTCCTTCTTTCAATAAACGACGCAGAGCGGCAAAATAATACTCCTGTCCGTTGGCCAACTCAGGCATGTAGATCGCCTCCACTCCATAAGAGAGTGCCAGGTGACGCATCGTTTTCTCCTTATAACAAA TGGCAAGCACCGGATATTTACCACGGAAAGCAGCCAGATTACGTGCAGTGCGCCCTTGATAGCTATCAGTAATGATAGCGCGTATTTTTAGTTTAGTAGTTGCTTTCACAGCCTGTTTGGCAAGGAAAGCAGTCACGTCATTACTATTCTCATCCAGAGGAATACGGATATCATTTTCTTCCAATTTGTC TTTTTCAGCCTGTGCAGCAATCTTAGTCATGGTTTTCACAGCCTCCACCGGATATTTACCATACGCGGTTTCACCACTCAACATCAGAGCATCCGTACGATAATAGATAGCATTCGCAATATCGGTTACTTCAGCACGAGTCGGACGCGGATTATTTATCATCGTATGTAACATCTGTGTAGCTACGATT ACCGGCTTCTTGGCAAGAATACATTTACGTATCAATGTACGCTGAATTCCCGGAATGCGTTCCTGTGGAACTTCAATACCCAAGTCACCGCGAGCTACCATCACTCCATCAGCAACTTCCAGAATCTCATCTATATTATCTACACCTTCTTGATTCTCTATCTTAGCAATAATACGGATATCGCTGTTGT GTGCATCCAGAATTTCACGAATATCAAGCACATCCTGACGGTTACGTACAAAAGAATGTGCTATGAAATCGATATCTTTTTCTATCGCATAAAGAATGTTATTACGATCTTTTTCAGTCAGAGAAGGCAGGTTGATGCGGACCCCGGGAACATTTACACTCTTACGGCTCCCCAAGGTTGCTTCATTCTG CACCTCACAAAGTAAATATTCGGACGTTTTATCAATAACCCGCAACTCAAGATCACCATCGTCAATCAAAATAGTTCCACCTATATTCAGATCGTGTACGAAATTCGGATAAGAAACGGCAATACATTCACGGGTAGTCTCACGTTCGGGATCCCCCACAATTTTAACCTTCTCGCCAATCTGATAAAGT ATTGGTTCCGCATTGGCAGTGGTACGTACCTCCGGACCTTTAGTATCCATAAGGATAGCGATGCGATTGGACACGGTACGAACATTGGCAATCAACGCTTCAAACCCTTCACGACTGGCGTGAGCTGTGTTCATACGAACCACATTCATCCCTGCATCAAACAACTCTTTTATAAAATCTACATCGCA ACGTCTGTCTGAGATGGAAGCTACGATTTTAGTCTGTTTCAGCAACATAATCTATCTACCTATTTATATTTATACCTATTTATCTAATAAAGCCTCAAGTGCCAGACGATATGAGTTCAATCCAAATCCACAAATCACACCTTTACAGGCACAAGCAATCATAGAAACATGACGGAACGACTCGCGGGCAT GAACATTGGAAATATGAACCTCAATCACAGGAGAGGGAACGGAACGGATGGCATCCTGCAAAGCAATGGAAGTGTGCGTATAAGCTCCTGCATTCAAAATGATTCCATCCACATCGAAACCGGTCTGCTGAATTTTATCTATCATTTCTCCTTCAACGTTCGACTGGAAATAACCCAACTCCACATCG GGATATTTTTTACGAAGCTCACCTAAATACTCTTCAAATGTAACGCTTCCATATATAGAAGGTTCACGCTTGCCCAAAAGATTAATATTGGGACCATTAATAATTTGTATCCTCATAACACAATCCTGCTATTTTTAATACCTTTGTCTTCGAGAACAATATTTCAAGATGCAAAGGTAGAAAAAAGAAATGA AATTAGACGAAAAAACAAAAAAGAAGGATGTGCAAGGGTTGATTATCAAAAAGTACCAACAGTATCTGAAACTGGAAAAGTCATTATCCGAAAACACATTGGATGCTTATTTGACGGATTTGGACAAGCTATTGAACTTTTTATCGGCCGAAGGTGTGGATATACTGGAAATCAGCCTGAAAGACCTTCA GCGTTTTGCAGCCGGACTGCATGATATCGGTATCCATGCCCGGTCACAGGCACGCATCATTTCCGGCATCAAGTCTTTCTTCCATTTTCTGATAATGGCCGATTATATAGAAGCTGATCCGAGTGAATTACTGGAAGGTCCCAAGATTGGTTTTAAACTACCGGAAGTATTGACTGTAGAGGAAATAGA CCGTATCATCTCAACTGTAGATCTGAGCAAAAATGAGGGACAGCGAAATCGGGCAATATTGGAGACACTCTATAGCTGTGGTTTACGGGTTTCGGAATTAACCAACTTAAAACTATCAGATCTTTATTTTAATGAAGGATTCATTAAAGTAGAAGGAAAAGGTAGTAAACAACGATTGGTGCCCATCTCC CCCAGAGCCATTCAGGAAATAAAATACTATTTCATGGATCGAAACCGGATTAACATAAAAAAAGATTATGAGGATTATCTGTTTTTAAGCAGACGGGGAACACACCTATCACGTATCATGATCTTTCATCTTATCAAAGAACTGGCCGATATGGCAGGTATCACCAAAAACATCAGTCCACACACATTCC GGCATTCTTTCGCAACACACCTTCTTGAAGGAGGCGCCAACCTGAGAGCTATTCAATGCATGCTCGGACATGAATCAATTTCGACCACCGAGATTTACACACATATCGACCGTAATATGCTGCGAAGTGAAATCATAGAACACCATCCGCGCAACATCAAATATCGGCAAGAAAAAAGGCATTTCAAT AAACAATAAAGTCTGGTTTGGCGTTATTTAGAGAGAGAAATAGTGCTGAACAGCTCAGGAATGCGACAGTTTTCATTAAATTATAATAAAATTAAGGGTGTATTTGCCTAAATGTATAAGAATTAATATCTTTGCGTGGCATTTATGGGCAATCCACAGATGCGTATTGAATAGACAAAATTTCAATTACAA ACATTTAATTTATACCTAAAATGATCAAGAAGTTGTATTTGCCTTTACTTATGGCATTGGTTGTTGCATTGTCATCATGTAGCAACAAAATGGGTGCACTGTCATCTGATTACTTCACTACGACTCCTCAGGTACTGGAAGCTGTAGGTGGTAAAGTTCCTGTGACTATCAACGGAAAGTTCCCTGAAAAG TATTTCAAAAAGAACGCAGTTGTTGAAGTAACTCCGGTCCTGAAATGGGAAGGTGGACAAGTGAAAGGACAGCCTGCTGTATTCCAGGGTGAAAAGGTAGAAGGTAACGACCAGACTATCTCTTACAAGATGGGTGGTAATTACACGATGAAAACTACATTCGACTATGTTCCTGAAATGGCTAAGTC TGAACTGTACCTTGAATTCAACGCAAAAGTTGGAAAAAAAACAATCGCTATCCCTGCAGTGAAGATCGCAGACGGTGTGATCTCTACTTCTGAATTGATTAACAATACTTTGAGCAGCGCTAATCCGGCTTTGGGTGACGACGCTTTCCAACGTATCATCAAAGAAGCACACAACGCTAACATCATGTT CCTTATCCAACAGGCTAACATCCGTTCAAGCGAATTGAAAACCGCTAAGGAATTCAACAAGGAAGTTGCTAACGTAAACGATGCAGAAAACAAAAAGATCAGCAATATCGAAATTTCGGCTTATGCTTCTCCTGATGGTGGTGTGAAACTGAACACAGGTTTAGCTGAGAACCGTGAAGGTAACACTA CTAAACTGATCAATAAAGACCTGAAGAAAGCTAAAATCGAAGTTCCGGTTGATGCTAAATATACTGCTCAAGACTGGGAAGGTTTCCAGGAACTGGTTTCTAAATCAAACATTCAGGATAAAGAACTGATTCTTCGTGTTCTGTCTATGTATCAGGATCCGGAACAAAGAGAGACAGAAATCAAAAACAT CTCTTCTGTATACAAAACTTTGGCTGACGAAATCCTGCCGCAGTTGCGTCGTTCTCGTTTGACTTTGAACTATGAAATCATCGGTAAGTCTGATGAAGAAATCGCTAATCTGGCTGCAACAGATCCGAAACAGTTGAATCTGGAAGAAATCCTGTATGCTGCTACACTGACTAACGACCCGGCTAAGAA AGCTGACATCTATACAAAAGCTTCTCAGCAGTTCCCGAATGACTACCGTGCATTCAACAACTTGGGTAAACTGGCTTATCAAGCAGGTGATTTGGACAAGGCTCAATCATACGTGAAAAAAGCAGAAAGCATTAAAGCTGCTCCTGAAGTAAACATGAACTTAGGTTTGATCGCTCTGGCTAAGGGTG ACAAAGCTGCTGCTGAGTCATACTTAGGTAAAGCTGCCGGTGCTAAAGAACTGAACGAAACATTGGGTAACCTGTACGTAGCTCAGGGACAATACGAAAGAGCAGTAAACGCATTTGGAGACACTAAAACAAACAGTGCTGCTTTGGCACAGATCCTGGCTAAGGACTACAACAAAGCTAAAAACAC TTTGGCTGGTATCTCAACTCCGGATGCTTACACA 0.2% of data from the machine Put data in to big computer Push button on big computer 26
27 Results from big computer (B. fragilis) 27
28 Case: Blood culture with B. fragilis Mikrobiologen, Sunderby sjukhus, Luleå MIC (mg/l) Imipenem: 12 Meropenem: >256 Piperacillin-tazobactam > Clindamycin 2 Metronidazol 0.25 imipenem-edta doubble-etest NEGATIVE!? Mechanism?
29 Phenotypic tests Meropenem-EDTA or imipenem-edta doubble-etest to demonstrate MBL which one? 29 MALDI-TOF with the right peaks cfia+
30 Case: Blood culture with Parabcteroides goldstenii Odense Universitetshospital MIC (mg/l) Meropenem: >256 Piperacillin-tazobactam > Clindamycin >32 Metronidazol 0.25 imipenem-edta og meropenem-edta doubble-etest POSITIVE (Ratio 8) Mechanisms?
31 WGS workflow for dummies 31 Sample on machine Data from machine
32 TGTCGCTTTCAGGTCACCAGTACCTGAACCTAAGGCCGGCACTTCGATAACAGCTTGATTGTAAGACAGCACATTTACCCCTTCCGTATATTTAGACTCCTGGTTGAAACCGGCCATTACGCTAAAATGGTGGTCTTTCTTAATATCAAACTTATATGTACCATAAATATTGAAGGCATTGTAATCGGTG AACTGTTTTTCTTTCTGCAAATAGTCTTTTGCAGCATTCCAGATGTTGTTACCTCCCTGTATGTCTGTATACTGAGTTTTTCCGGTATAGAAATTATAGTCATACATGTTTTTGTCAAACGTGTATTCAAATACCCCTTCAAAGCCTTTGAATGGCTTCAAAATAGATTTCACGAAAACACGCGGATTGTCAT ATGACTTTTTCCATTTATTCGCCAACAACACCTGATTACGCGGTGTATTGAAAGGCAAATCCTGAGAGATTGTAGAACAAACGTCCGCAGGCATATTACCTTCCGGTTGATAAGAAACCTGATTACTACCGAACATGCTTCCCAGACCGGAACTCGGTTGTGACTGATTGGTACGCGCATAGCTCATTG TCAGTTCCTGAGTAAACCATTTGGTAATATCAGCAGAAATATAAGAATTGATATTCAGACGTTCATACGTATCTTTATCGGTAATCAAAACACCGTCCGTAGATACATATCCGGCTGACATACGGTAACGCAACTTATCTGTACCGCCGGATACAGAAAGATTATGATTCATCTGGAAACTGGTCTCCAT AAAATTCTTATATGGATCATGTTCGTTCAGATAATACAAGGCTCCGTCCGTATCGGCAAAAATACCATCACCTACAGTTTTGATAGATGAAGGATCCTGCCTGTACTGTGTCAGGTATTCCTTCCATTTTGAAACACTGGGTGAACCATAAGACCAATAAGCATCAGAATATCCTCCATCCTGATAAGCC TGCAGGTAATCCATTAACGATGCTTGCTTCGGCAGATTCATTGCAGTAGCAAAACCGAAATTATTGTTATAGTTCAGGCGGAAAGCCGTAGCTTCTTTCGGGCGCTTAGTAGTCACCAAAACCACACCACCGGCCGCACGCGCACCATAAATAGCTGCCGAAGCAGCATCTTTCAGTACCGTCACCG TTTCGATATCTTCCGGATTCAACATGTCGAGGCTACCCTCTACGTTATCAATCAAGATAAGAGGCGCGACATTGGCACCATAGCTTCCGTCGCTATTCTTGATACCTACTGAATAGGCACCACGCAGTTGGAATGACTTTCCGCTACCCGGTGCATTCCCGCTATTAGATACCAGCAGTCCCGGAACC GTACCTTGCAATGCATCGGAAGCTGTCATAATAGGACGGTCCCCGATAATCTCATCCATTTTGATAGATGAAACAGCACCTGTCAAGTTTGCTTTCTTTTGTGAACCGAAACCGACTACCACTACTTCGTCTAAGGTACGAGAGTCATCTTTCAGCACTATCTTCAAAGGAACACCGGCCACGGCTTTC ACTTCTTGTGTTACATAACCGATATAAGAGATAACGATAACAGCACCCGGATTTACCGACAAAGAGAAATTTCCCTCTACATTACTGATCGTACCATTCTGGGCATTGTTTTTTTCCATAATGGTAGCACCAATAATCGATTCTCCCAGGTTATCCCTGATATTACCTTTTACAACGATCTTATTACTCTGC TGTGGTGTGGAAACTACCTCCGGAGCACTCTTCAGAATAACTTCATTGCCCTTGATGACATAGCTGATACCACTGTCTTTAAACAGCACATTCAGTACCTCCTCTATGGAGCCTTCACAATTGATGTCACGGATCTTTGCATTACCCAAATCGGCTGCCTTGTAAAAGAACGTATATTTACTGTTCTTTT CAATAACCTGGATGGCCTGTTTAATGCTCATTGCCTTTCCCTGCACGGCTATCTGTCCCTGCACGGCAAAAACGGACATAGGATACAGGAGCATAAACATAATTACGCCTGCCAGAAAACGCCTGTTACAGACGCTAAAACATTGTCTCATGTCTTTCATTTTTTTGATTATACGATTAATTAGTGATTG ATAAAAAAGCGATTATTTATAAATAATGATTCTCTGTGTTTCTTTTCTAAATTTCAAATTCATATTGATACAAATCTTTTCGATAACTTTAGATGCGGGGTCATCATAACGCATATAGCCTGTGAACAAGTCATTTCGGGATACTTTCTCGTCGAGCTCTACCGGAATATGGTAAATATCATGAATGGCTTCT ATCAAATCATCCATACGCATGTCGACAAATTTGTAACGTCCCTCATCCCAACTGATATTACCTATATTCTTTAATATCACTTCATCCTTTTCGGGATGAAAAATAATCTGTTGCAAAGGTTTCATTTCAATCTTCCTCTGCGAAGCCTTAGCGTTGAAATCAACCTTTCCACTAAAAAGAGTCACTTCCGCA CCATACTGCCGGGTGGACTGAACACGAAAAACCGTCCCTTTGACTTCTACAAATGCCTGATCAATATATACCTTAAAATTACGTCCCTTACGTTTGGTTACCTCAAAAGTAGACTCTCCCTCCAACCAGACTTCCCGTTTATCCATAAAGTCCTGTGAAAAACGGATTCGACTTCCGGCTTGCATCCAA ACCCTTGAACTGTCGGGGAGCACGTACAACCGGCTATTTGAAGAAACAATCTCAGTATACTCAATGATATGTTGCGAAGTGACAGGCTCCTCATTAAAAAAGAAGATACTTCCCCCAACAACCAATAACACTGTAATACATGCAGCGAGAGCAATCTTCAAGTACCTGAGCTGGAGCCGTTGCTTACG TTCAAAAGGAGTCTGACATTTGGAATCAATCTTATTCCAAATCCTACTTTCAACAGCAGCATCATCCACTATATTCCTTGCAGCATCAAATTGTTTTTTCATCTTTGTCTCCACAACATCCCAGTGCGCCAGCTCTTCTACTTCTCCCGGAGAAGACTTACCGGCAATCAATTTGCGGACAAGCCGATCG TATTTATTAGAAATCTTCATATTCTTTATATTTCTTTCCAAAAGCCCAAGCTATATTTATAAATCTATCCATAAATACACAATTTATAAAATTCCCCCCTATATGTTTTCCGCTTTTTTTCTGTTTTATAAATTGAGTATGCTATATTTGTAATCCAAACGTAACTCTTAATGAACGAAAAAGAAGCAATTATTAA ACTGAAGACCCGCAATGATAAAGCTGCCTTTGCATTCCTGTACCACTCTTATTGGGCTAAGGTTTACAACTTTACGCGACTTTATGTCACTTCTTTGGTTGATGTGGAGGAAATCGTTCAAGAGGTTTTTATTAAAATCTGGGAGAGCAGAGAGTCTTTGGATGAAGAGCAAAACTTTGCAGGATATCTG TTCATCACCATGCGTAACCTTGTTTTTAACCGCTCCCGCAAGAATCTGAACGAGGCTTTCTACCAACTGTCAGTGATAGAAGCAGTAGAAGAGTCATATGATATAGAAGAAGAACTGGATGCAGCCAATCTACGGACACATATCGAATCACTTATTTCAATGTTACCACCCCGGCAACAGGAAGTATTC CGTCTGAGCAGGGACGAAGAACTTTCTTATCGTGAAATTGCAGAGAAACTGCAAATATCGGAAAGAACAGTGGAACACCACATATCCGATGCTTTGAAGTTTCTAAGAAAAAACATCAAGCTTTACACATTATTCCTTTCATTATAAATGAAGTAGCGCTGCTCTTCCCCGTTGGGACAGAACAGCGCC GATCATCAGTTTTTTATGAAAAACGAAACTTTCTTTCATAGAGAGGTATTACACTTACATAACAATTCTCTCTTCACAGAGATACTATTAACACTATATATAAACATGATGATTTTCATTAATAAATCAAAAATAAACATTTCTATAAAAATAAGAAATGGAAATCGACTAATAGAACAATTTAATCGATCAAAA TGTTCTCTACATTTTCAGTAAACGTTTACTCAAATACCTTACCGGATACCAGACAGATAAAAATCCGACAGTAAATACGGTAATAAATATCACGATGACATCCCCCAAATGAACACTGACCGGATAGGAATCAACTACAAAATTACCTGCAGCATTACCTCCACCCAATGAAACTATCCCGTAGGCCATC TGAACCCAACATAGAACCAAGCCGAGTATAATCCCGATTATAGCCCCATAAAAGGAAATCATACATCCTTCGAAAAGGAAAATACGCGAAACAAGCCGATCGTCAGCTCCCAATTTACGAAGTGTATTCACATCTTCCTTTTTATCCAGAATAAGCATCGACAGCGAACCTATCACATTGAAACAGGCG ATCACGAGAATAAAGGTAAGAAACAAATACGAAACCAATTTCTCTATCTCCATGATGCGAAACACATCCTCCTGCTGCTCGTAACGGTTACGAATAACAAAACCATCTCCTAACGCCTTCCCGATCTTTTCTTTCACTACAGAAATATTAGATCCCGGCTTTAGTTTCAGTTCTATTGCAGACACTTCGGT AGTATAATCAAGCAAACGCCGGGCAAAATCCAACGAAGTGAGAATATACTGTCCGTCATACTTCTGCTGATTGACTACAAACACTACACCGGGCGAATACAAATAATCCATATTAAAGGAAGCAGCCGGATTTGCAAGATTAACCTTTCCATTCCTTTTAGGAATATATACCTGCAAAGGATCGACAAA CCTGATTCCGGTCCCCAATGTAGAGACAAGCTCAATCCCCATCACTCCATAATCCACAACAGAATCGTTCAACAAAAACTCACCTGCTCCATAAAGGATACTATCTATTGCAGTCAACTGCTCAAAATTATCTTGTACCCCCTTTATAACAGCCATTGTTTGACGATCCTTGTATTGCACCATCGCATTC TCTTCAAGTGTTTCAGTCAACACATCTACTTCCGGCATCTGCCGGATAGCCTGAATACGCGGGTCCTGTGCATCGAAAACTTTCCCTTCGGCAATCGTCACTTTCAGTTCCGGATCAAACACAGTAAACAGATCGGCTACTGTATCCTGAAAACCATTGAATACGGAAAGTGTACACACCATTGCCATC GTAGCCAATGCTACTCCACACACGGAAATAGCCGAAATGATATTAATGGCATTGTGTTTCTTCTTTGAGAAAAGATATCGCCGGGCTATGTAGAAGGGAAGATTCACTTCAACAAGGCATCTATCTTTTCAATGTAGTCCAGCGAATCGTCCACAAAAAATTTCAATTCGGGGATAATACGCAACTGAT GACGAACACGGGTACCGAGTTCGAAACGGATGGACTTCATATTATTATTGATATTCTTTACCATTTCTTCGCTTTTATCAGAAGGGAAGACACTTAAATATACGCGGGCAATGCTCATATCAGGGCTGATACGTACAGCACTGACAGATACCAACACACCGGGCATGGCCTTGGTCTGCAACAGAAAA ATCTCACTGAGTTCTTTCTGTAACAAACGGGCTATCTTATTCTGTCTCGTTGTTTCCATAAACTTTCTACGTAATTATTTTATCAAACAAGCAATTAGCACTTGTTACAATAGAACACAAAATTAGAGAAATATATCGTTTGACAGATAAAATATGTACTATTTTTAATCTTCATTATTGAATTATTCTTCCAAT GCTAAAGAGTAATCAACTAATACACATCTCACTTTTTACGAATAATGGTCAGTCCATCACGCAAAGGGAGGATTACTTTCTCCACTCGTTCATCATGTGCCACCAATTCGTTGAAAGCCTTAATACCGATGGTTTGATAGTCGTTGTTATGTGGCTCTTCCAGCACATGACCATCCCATAAAGTGTTATC GGCTATGATATATCCTCCGGGAGAAAGATGCGCAAGAGTCATCTCATAATATTCAATATACTTACGTTTATCGCCATCCACAAAAGCAAGGTCAAACGTAACTCCCAATGCAGGTATCAATTGGAGAGCATCTCCAATGTAGAATTTAATTTTATCAGCATAAGCTGAATTTTCGAGCCAGGGACGGGT AAAGTCTTCCTGTTCGTCATTTATCTCAAATGTGTGGAGCATTCCACCCTCCTCAAGTCCTTCGGCCAAGCAAAGGGCGGAATAGCCACTATAAGTTCCTATTTCTAATATCTGGCGAGGCCGTATCATACGAACAAACATCTTCAACATACGCCCCTGCAGATGACCGGAAGCCATACGGGGACGCA GAAGCTTGACATGCGTATCCCGATAAAGAGCTTTCAGGTATTCACCTTCTTCATCGATATGCTTTAGGATATATTCGTCTAAAAGATCGGTCTCTTTCATCTCATCCTACAGATAACGGTTGCTGTTAGGCAATACACTGTCACCGGCATGCTTCAAAGCATCTTCCACGACATTGATCTCAAGGAAAGA GGTTTGTGTCCCGGCTTTACCGCTACTCAGATAACCCACCATATCAGTAGGATGTAAACGTCCTTCTTTCAATAAACGACGCAGAGCGGCAAAATAATACTCCTGTCCGTTGGCCAACTCAGGCATGTAGATCGCCTCCACTCCATAAGAGAGTGCCAGGTGACGCATCGTTTTCTCCTTATAACAAA TGGCAAGCACCGGATATTTACCACGGAAAGCAGCCAGATTACGTGCAGTGCGCCCTTGATAGCTATCAGTAATGATAGCGCGTATTTTTAGTTTAGTAGTTGCTTTCACAGCCTGTTTGGCAAGGAAAGCAGTCACGTCATTACTATTCTCATCCAGAGGAATACGGATATCATTTTCTTCCAATTTGTC TTTTTCAGCCTGTGCAGCAATCTTAGTCATGGTTTTCACAGCCTCCACCGGATATTTACCATACGCGGTTTCACCACTCAACATCAGAGCATCCGTACGATAATAGATAGCATTCGCAATATCGGTTACTTCAGCACGAGTCGGACGCGGATTATTTATCATCGTATGTAACATCTGTGTAGCTACGATT ACCGGCTTCTTGGCAAGAATACATTTACGTATCAATGTACGCTGAATTCCCGGAATGCGTTCCTGTGGAACTTCAATACCCAAGTCACCGCGAGCTACCATCACTCCATCAGCAACTTCCAGAATCTCATCTATATTATCTACACCTTCTTGATTCTCTATCTTAGCAATAATACGGATATCGCTGTTGT GTGCATCCAGAATTTCACGAATATCAAGCACATCCTGACGGTTACGTACAAAAGAATGTGCTATGAAATCGATATCTTTTTCTATCGCATAAAGAATGTTATTACGATCTTTTTCAGTCAGAGAAGGCAGGTTGATGCGGACCCCGGGAACATTTACACTCTTACGGCTCCCCAAGGTTGCTTCATTCTG CACCTCACAAAGTAAATATTCGGACGTTTTATCAATAACCCGCAACTCAAGATCACCATCGTCAATCAAAATAGTTCCACCTATATTCAGATCGTGTACGAAATTCGGATAAGAAACGGCAATACATTCACGGGTAGTCTCACGTTCGGGATCCCCCACAATTTTAACCTTCTCGCCAATCTGATAAAGT ATTGGTTCCGCATTGGCAGTGGTACGTACCTCCGGACCTTTAGTATCCATAAGGATAGCGATGCGATTGGACACGGTACGAACATTGGCAATCAACGCTTCAAACCCTTCACGACTGGCGTGAGCTGTGTTCATACGAACCACATTCATCCCTGCATCAAACAACTCTTTTATAAAATCTACATCGCA ACGTCTGTCTGAGATGGAAGCTACGATTTTAGTCTGTTTCAGCAACATAATCTATCTACCTATTTATATTTATACCTATTTATCTAATAAAGCCTCAAGTGCCAGACGATATGAGTTCAATCCAAATCCACAAATCACACCTTTACAGGCACAAGCAATCATAGAAACATGACGGAACGACTCGCGGGCAT GAACATTGGAAATATGAACCTCAATCACAGGAGAGGGAACGGAACGGATGGCATCCTGCAAAGCAATGGAAGTGTGCGTATAAGCTCCTGCATTCAAAATGATTCCATCCACATCGAAACCGGTCTGCTGAATTTTATCTATCATTTCTCCTTCAACGTTCGACTGGAAATAACCCAACTCCACATCG GGATATTTTTTACGAAGCTCACCTAAATACTCTTCAAATGTAACGCTTCCATATATAGAAGGTTCACGCTTGCCCAAAAGATTAATATTGGGACCATTAATAATTTGTATCCTCATAACACAATCCTGCTATTTTTAATACCTTTGTCTTCGAGAACAATATTTCAAGATGCAAAGGTAGAAAAAAGAAATGA AATTAGACGAAAAAACAAAAAAGAAGGATGTGCAAGGGTTGATTATCAAAAAGTACCAACAGTATCTGAAACTGGAAAAGTCATTATCCGAAAACACATTGGATGCTTATTTGACGGATTTGGACAAGCTATTGAACTTTTTATCGGCCGAAGGTGTGGATATACTGGAAATCAGCCTGAAAGACCTTCA GCGTTTTGCAGCCGGACTGCATGATATCGGTATCCATGCCCGGTCACAGGCACGCATCATTTCCGGCATCAAGTCTTTCTTCCATTTTCTGATAATGGCCGATTATATAGAAGCTGATCCGAGTGAATTACTGGAAGGTCCCAAGATTGGTTTTAAACTACCGGAAGTATTGACTGTAGAGGAAATAGA CCGTATCATCTCAACTGTAGATCTGAGCAAAAATGAGGGACAGCGAAATCGGGCAATATTGGAGACACTCTATAGCTGTGGTTTACGGGTTTCGGAATTAACCAACTTAAAACTATCAGATCTTTATTTTAATGAAGGATTCATTAAAGTAGAAGGAAAAGGTAGTAAACAACGATTGGTGCCCATCTCC CCCAGAGCCATTCAGGAAATAAAATACTATTTCATGGATCGAAACCGGATTAACATAAAAAAAGATTATGAGGATTATCTGTTTTTAAGCAGACGGGGAACACACCTATCACGTATCATGATCTTTCATCTTATCAAAGAACTGGCCGATATGGCAGGTATCACCAAAAACATCAGTCCACACACATTCC GGCATTCTTTCGCAACACACCTTCTTGAAGGAGGCGCCAACCTGAGAGCTATTCAATGCATGCTCGGACATGAATCAATTTCGACCACCGAGATTTACACACATATCGACCGTAATATGCTGCGAAGTGAAATCATAGAACACCATCCGCGCAACATCAAATATCGGCAAGAAAAAAGGCATTTCAAT AAACAATAAAGTCTGGTTTGGCGTTATTTAGAGAGAGAAATAGTGCTGAACAGCTCAGGAATGCGACAGTTTTCATTAAATTATAATAAAATTAAGGGTGTATTTGCCTAAATGTATAAGAATTAATATCTTTGCGTGGCATTTATGGGCAATCCACAGATGCGTATTGAATAGACAAAATTTCAATTACAA ACATTTAATTTATACCTAAAATGATCAAGAAGTTGTATTTGCCTTTACTTATGGCATTGGTTGTTGCATTGTCATCATGTAGCAACAAAATGGGTGCACTGTCATCTGATTACTTCACTACGACTCCTCAGGTACTGGAAGCTGTAGGTGGTAAAGTTCCTGTGACTATCAACGGAAAGTTCCCTGAAAAG TATTTCAAAAAGAACGCAGTTGTTGAAGTAACTCCGGTCCTGAAATGGGAAGGTGGACAAGTGAAAGGACAGCCTGCTGTATTCCAGGGTGAAAAGGTAGAAGGTAACGACCAGACTATCTCTTACAAGATGGGTGGTAATTACACGATGAAAACTACATTCGACTATGTTCCTGAAATGGCTAAGTC TGAACTGTACCTTGAATTCAACGCAAAAGTTGGAAAAAAAACAATCGCTATCCCTGCAGTGAAGATCGCAGACGGTGTGATCTCTACTTCTGAATTGATTAACAATACTTTGAGCAGCGCTAATCCGGCTTTGGGTGACGACGCTTTCCAACGTATCATCAAAGAAGCACACAACGCTAACATCATGTT CCTTATCCAACAGGCTAACATCCGTTCAAGCGAATTGAAAACCGCTAAGGAATTCAACAAGGAAGTTGCTAACGTAAACGATGCAGAAAACAAAAAGATCAGCAATATCGAAATTTCGGCTTATGCTTCTCCTGATGGTGGTGTGAAACTGAACACAGGTTTAGCTGAGAACCGTGAAGGTAACACTA CTAAACTGATCAATAAAGACCTGAAGAAAGCTAAAATCGAAGTTCCGGTTGATGCTAAATATACTGCTCAAGACTGGGAAGGTTTCCAGGAACTGGTTTCTAAATCAAACATTCAGGATAAAGAACTGATTCTTCGTGTTCTGTCTATGTATCAGGATCCGGAACAAAGAGAGACAGAAATCAAAAACAT CTCTTCTGTATACAAAACTTTGGCTGACGAAATCCTGCCGCAGTTGCGTCGTTCTCGTTTGACTTTGAACTATGAAATCATCGGTAAGTCTGATGAAGAAATCGCTAATCTGGCTGCAACAGATCCGAAACAGTTGAATCTGGAAGAAATCCTGTATGCTGCTACACTGACTAACGACCCGGCTAAGAA AGCTGACATCTATACAAAAGCTTCTCAGCAGTTCCCGAATGACTACCGTGCATTCAACAACTTGGGTAAACTGGCTTATCAAGCAGGTGATTTGGACAAGGCTCAATCATACGTGAAAAAAGCAGAAAGCATTAAAGCTGCTCCTGAAGTAAACATGAACTTAGGTTTGATCGCTCTGGCTAAGGGTG ACAAAGCTGCTGCTGAGTCATACTTAGGTAAAGCTGCCGGTGCTAAAGAACTGAACGAAACATTGGGTAACCTGTACGTAGCTCAGGGACAATACGAAAGAGCAGTAAACGCATTTGGAGACACTAAAACAAACAGTGCTGCTTTGGCACAGATCCTGGCTAAGGACTACAACAAAGCTAAAAACAC TTTGGCTGGTATCTCAACTCCGGATGCTTACACA 0.2% of data from the machine Put data in to big computer Push button on big computer 32
33 Results from big computer (P. goldsteinii) 33 WHAT???
34 Conclusion No single completely perfect method for carbapenemase characterization Use a mixture of methods if possible Whole genome sequencing is definitely an excellent confirmatory tool 34 Thank you for your attention! the second mentometerfråga
Streptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance
Streptococcus pneumoniae Oxacillin µg as screen for beta-lactam resistance Version 6. June Streptococcus pneumoniae and zone diameter correlates The following histograms present inhibition zone diameter
More informationon February 12, 2018 by guest
AAC Accepted Manuscript Posted Online 12 February 2018 Antimicrob. Agents Chemother. doi:10.1128/aac.00047-18 Copyright 2018 Stapert et al. This is an open-access article distributed under the terms of
More informationHelp with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST
Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to
More informationNew Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs
New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs Patrick R. Murray, PhD Senior Director, WW Scientific Affairs 2017 BD. BD, the BD Logo and all other trademarks
More informationMICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC
MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical
More informationWhat s new in EUCAST methods?
What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests
More informationCase Report Multidrug-Resistant Bacteroides fragilis Bacteremia in a US Resident: An Emerging Challenge
Case Reports in Infectious Diseases Volume 2016, Article ID 3607125, 4 pages http://dx.doi.org/10.1155/2016/3607125 Case Report Multidrug-Resistant Bacteroides fragilis Bacteremia in a US Resident: An
More informationEUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM)
EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM) Christian G. Giske, MD/PhD Chairman of ESDReM Karolinska University Hospital and EUCAST ECCMID, 22 maj 2013 The background Guidance on
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The
More informationShould we test Clostridium difficile for antimicrobial resistance? by author
Should we test Clostridium difficile for antimicrobial resistance? Paola Mastrantonio Department of Infectious Diseases Istituto Superiore di Sanità, Rome,Italy Clostridium difficile infection (CDI) (first
More informationPrevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 952-956 http://www.ijcmas.com Original Research Article Prevalence of Metallo-Beta-Lactamase
More informationESCMID Online Lecture Library. by author
Quality Assurance of antimicrobial susceptibility testing Derek Brown EUCAST Scientific Secretary ESCMID Postgraduate Education Course, Linz, 17 September 2014 Quality Assurance The total process by which
More informationRoutine internal quality control as recommended by EUCAST Version 3.1, valid from
Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus
More informationESBL Producers An Increasing Problem: An Overview Of An Underrated Threat
ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic
More information1 INTRODUCTION OBJECTIVES OUTLINE OF THE SALM/CAMP EQAS
PROTOCOL For antimicrobial susceptibility testing of Salmonella, Campylobacter and optional genotypic characterisation of AmpC-, ESBL- and carbapenemase-producing test strains 1 INTRODUCTION... 1 2 OBJECTIVES...
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01
More informationEUCAST recommended strains for internal quality control
EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC
More informationPROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains
PROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains 1 INTRODUCTION... 1 2 OBJECTIVES... 2 3 OUTLINE OF THE EQAS 2017... 2 3.1 Shipping, receipt and storage of strains...
More informationFlorida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC
Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC 11/20/2014 1 To describe carbapenem-resistant Enterobacteriaceae. To identify laboratory detection standards for carbapenem-resistant
More informationQuality assurance of antimicrobial susceptibility testing
Quality assurance of antimicrobial susceptibility testing Derek Brown Routine quality control Repeated testing of controls in parallel with tests to ensure that the test system is performing reproducibly
More informationEDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update
EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain
More informationSuggestions for appropriate agents to include in routine antimicrobial susceptibility testing
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory
More informationComparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria
Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria Juhee Ahn Department of Medical Biomaterials Engineering Kangwon National University October 23, 27 Antibiotic Development
More informationAntimicrobial Susceptibility of Clinically Relevant Gram-Positive Anaerobic Cocci Collected over a Three-Year Period in the Netherlands
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Mar. 2011, p. 1199 1203 Vol. 55, No. 3 0066-4804/11/$12.00 doi:10.1128/aac.01771-09 Copyright 2011, American Society for Microbiology. All Rights Reserved. Antimicrobial
More informationMonitoring of antimicrobial resistance in Campylobacter EURL AR activities in framework of the new EU regulation Lina Cavaco
Monitoring of antimicrobial resistance in Campylobacter EURL AR activities in framework of the new EU regulation Lina Cavaco licav@food.dtu.dk 1 DTU Food, Technical University of Denmark Outline EURL-AR
More information56 Clinical and Laboratory Standards Institute. All rights reserved.
Table 2C 56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C. Zone Diameter and Minimal Inhibitory Concentration Breakpoints for Testing Conditions Medium: Inoculum: diffusion:
More informationMechanism of antibiotic resistance
Mechanism of antibiotic resistance Dr.Siriwoot Sookkhee Ph.D (Biopharmaceutics) Department of Microbiology Faculty of Medicine, Chiang Mai University Antibiotic resistance Cross-resistance : resistance
More informationAntimicrobial Resistance in Human Oral and Intestinal Anaerobic Microfloras
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1993, p. 1665-1669 Vol. 37, No. 8 0066-4804/93/081665-05$02.00/0 Copyright X 1993, American Society for Microbiology Antimicrobial Resistance in Human Oral and
More informationSESSION XVI NEW ANTIBIOTICS
SESSION XVI NEW ANTIBIOTICS New Antibiotics to Treat Anaerobic Infections 2 Goldstein, E.J.C.;* Citron, D.M. Antibiotic Pharmacodynamics 3 Stein, G.E.* Targeting Selenium Metabolism in Stickland Fermentors:
More informationPractical approach to Antimicrobial susceptibility testing (AST) and quality control
Practical approach to Antimicrobial susceptibility testing (AST) and quality control A/Professor John Ferguson, Microbiologist & Infectious Diseases Physician, Pathology North, University of Newcastle,
More informationOriginal Article. Ratri Hortiwakul, M.Sc.*, Pantip Chayakul, M.D.*, Natnicha Ingviya, B.Sc.**
Original Article In Vitro Activity of Cefminox and Other β-lactam Antibiotics Against Clinical Isolates of Extended- Spectrum-β-lactamase-Producing Klebsiella pneumoniae and Escherichia coli Ratri Hortiwakul,
More informationCompliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
More informationJanuary 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton
More informationAntimicrobial Resistance and Prescribing
Antimicrobial Resistance and Prescribing John Ferguson, Microbiology & Infectious Diseases, John Hunter Hospital, University of Newcastle, NSW, Australia M Med Part 1 updates UPNG 2017 Tw @mdjkf http://idmic.net
More informationAntimicrobial Susceptibility of Clinical Isolates of Bacteroides fragilis Group Organisms Recovered from 2009 to 2012 in a Korean Hospital
Original Article Clinical Microbiology Ann Lab Med 2015;35:94-98 http://dx.doi.org/10.3343/alm.2015.35.1.94 ISSN 2234-3806 eissn 2234-3814 Antimicrobial Susceptibility of Clinical Isolates of Bacteroides
More informationService Delivery and Safety Department World Health Organization, Headquarters
Service Delivery and Safety Department World Health Organization, Headquarters WHO global (laboratory-based) survey on multidrug-resistant organisms (MDROs) in health care PROJECT SUMMARY Given the important
More informationDefining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate Confirmation Testing
Infect Dis Ther (2015) 4:513 518 DOI 10.1007/s40121-015-0094-6 BRIEF REPORT Defining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate
More informationChallenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems
Micro 301 Antimicrobial Drugs 11/7/12 Significance of antimicrobial drugs Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems Definitions Antibiotic Selective
More informationChemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance
Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance evolution of antimicrobial resistance Mechanism of bacterial genetic variability Point mutations may occur in a nucleotide base pair,
More informationAntibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting
Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria
More informationDetecting / Reporting Resistance in Nonfastidious GNR Part #2. Janet A. Hindler, MCLS MT(ASCP)
Detecting / Reporting Resistance in Nonfastidious GNR Part #2 Janet A. Hindler, MCLS MT(ASCP) Methods Described in CLSI M100-S21 for Testing non-enterobacteriaceae Organism Disk Diffusion MIC P. aeruginosa
More informationIntroduction to Antimicrobials. Lecture Aim: To provide a brief introduction to antibiotics. Future lectures will go into more detail.
Introduction to Antimicrobials Rachel J. Gordon, MD, MPH Lecture Aim: To provide a brief introduction to antibiotics. Future lectures will go into more detail. Major Learning Objectives: 1) Learn the different
More informationThe Basics: Using CLSI Antimicrobial Susceptibility Testing Standards
The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information
More informationWHY IS THIS IMPORTANT?
CHAPTER 20 ANTIBIOTIC RESISTANCE WHY IS THIS IMPORTANT? The most important problem associated with infectious disease today is the rapid development of resistance to antibiotics It will force us to change
More informationENTEROCOCCI. April Abbott Deaconess Health System Evansville, IN
ENTEROCOCCI April Abbott Deaconess Health System Evansville, IN OBJECTIVES Discuss basic antimicrobial susceptibility principles and resistance mechanisms for Enterococcus Describe issues surrounding AST
More informationPrevalence of Extended Spectrum Beta- Lactamase Producers among Various Clinical Samples in a Tertiary Care Hospital: Kurnool District, India
International Journal of Current Microbiology and Applied Sciences ISSN: 319-77 Volume Number (17) pp. 57-3 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/1.5/ijcmas.17..31
More informationPrinciples and Practice of Antimicrobial Susceptibility Testing. Microbiology Technical Workshop 25 th September 2013
Principles and Practice of Antimicrobial Susceptibility Testing Microbiology Technical Workshop 25 th September 2013 Scope History Why Perform Antimicrobial Susceptibility Testing? How to Perform an Antimicrobial
More informationWhat is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups. by author. Gunnar Kahlmeter, Derek Brown
What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups Gunnar Kahlmeter, Derek Brown Izmir, February 2011 Anaerobes subcommittee EUCAST Subcommittee on breakpoints
More informationAntimicrobials & Resistance
Antimicrobials & Resistance History 1908, Paul Ehrlich - Arsenic compound Arsphenamine 1929, Alexander Fleming - Discovery of Penicillin 1935, Gerhard Domag - Discovery of the red dye Prontosil (sulfonamide)
More informationa. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
More information2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services
2015 Antibiogram Red Deer Regional Hospital Central Zone Alberta Health Services Introduction. This antibiogram is a cumulative report of the antimicrobial susceptibility rates of common microbial pathogens
More informationGlobal Alliance for Infections in Surgery. Better understanding of the mechanisms of antibiotic resistance
Better understanding of the mechanisms of antibiotic resistance Antibiotic prescribing practices in surgery Contents Mechanisms of antibiotic resistance 4 Antibiotic resistance in Enterobacteriaceae 9
More informationMethicillin-Resistant Staphylococcus aureus
Methicillin-Resistant Staphylococcus aureus By Karla Givens Means of Transmission and Usual Reservoirs Staphylococcus aureus is part of normal flora and can be found on the skin and in the noses of one
More informationEUCAST-and CLSI potency NEO-SENSITABS
EUCASTand CLSI potency NEOSENSITABS Neo Sensitabs Page 1 / 6 Document: 6.2.0 Fastidious organisms EUCAST Interpretation zones and MIC breakpoints according to recommendations by the "Comité de l'antibiogramme
More informationCompliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
More informationUNDERSTANDING YOUR DATA: THE ANTIBIOGRAM
UNDERSTANDING YOUR DATA: THE ANTIBIOGRAM April Abbott, PhD, D(ABMM) Deaconess Health System Evansville, IN April.Abbott@Deaconess.com Special thanks to Dr. Shelley Miller for UCLA data WHAT WE WILL COVER
More informationEducating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges
Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges Janet Hindler, MCLS MT(ASCP) UCLA Medical Center jhindler@ucla.edu also working as a consultant with the Association
More informationAntimicrobial Resistance and Molecular Epidemiology of Staphylococcus aureus in Ghana
Antimicrobial Resistance and Molecular Epidemiology of Staphylococcus aureus in Ghana Beverly Egyir, PhD Noguchi Memorial Institute for Medical Research Bacteriology Department, University of Ghana Background
More informationAcinetobacter Resistance in Turkish Tertiary Care Hospitals. Zeliha KOCAK TUFAN, MD, Assoc. Prof.
Acinetobacter Resistance in Turkish Tertiary Care Hospitals Zeliha KOCAK TUFAN, MD, Assoc. Prof. Acinetobacter Problem Countries that have reported hospital outbreaks of carbapenem-resistant Acinetobacter
More informationMulti-drug resistant microorganisms
Multi-drug resistant microorganisms Arzu TOPELI Director of MICU Hacettepe University Faculty of Medicine, Ankara-Turkey Council Member of WFSICCM Deaths in the US declined by 220 per 100,000 with the
More information2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose
2017 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility
More informationPresenter: Ombeva Malande. Red Cross Children's Hospital Paed ID /University of Cape Town Friday 6 November 2015: Session:- Paediatric ID Update
Emergence of invasive Carbapenem Resistant Enterobacteriaceae CRE infection at RCWMCH Ombeva Oliver Malande, Annerie du Plessis, Colleen Bamford, Brian Eley Presenter: Ombeva Malande Red Cross Children's
More informationInt.J.Curr.Microbiol.App.Sci (2018) 7(8):
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 08 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.708.378
More informationAntimicrobial Resistance Strains
Antimicrobial Resistance Strains Microbiologics offers a wide range of strains with characterized antimicrobial resistance mechanisms including: Extended-Spectrum β-lactamases (ESBLs) Carbapenamases Vancomycin-Resistant
More informationHelen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory
METHODS USED IN NEW ZEALAND DIAGNOSTIC LABORATORIES TO IDENTIFY AND REPORT EXTENDED-SPECTRUM β-lactamase- PRODUCING ENTEROBACTERIACEAE by Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory
More informationEUCAST Workshop: Antimicrobial susceptibility testing with EUCAST breakpoints and methods
EUCAST Workshop: Antimicrobial susceptibility testing with EUCAST breakpoints and methods Susceptibility testing of infrequently isolated fastidious organisms Luis Martinez-Martínez Service of Microbiology
More informationAntibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017
Antimicrobial susceptibility of Shigella, 2015 and 2016 Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017
More informationWhy we perform susceptibility testing
22 nd June 2015 Why we perform susceptibility testing Robin A Howe Antimicrobial use in Primary Care Why do we perform AST? Clinical Clinical Prediction Prediction of of Efficacy Efficacy Why do we perform
More informationSheffield User Group Day October Members of the BSAC Working party on Susceptibility Testing present:
Sheffield User Group Day October 2006 Members of the BSAC Working party on Susceptibility Testing present: Trevor Winstanley Jenny Andrews Robin Howe David Livermore (Meeting Chairman) [TW] (Speaker) [JA]
More informationIntroduction to Pharmacokinetics and Pharmacodynamics
Introduction to Pharmacokinetics and Pharmacodynamics Diane M. Cappelletty, Pharm.D. Assistant Professor of Pharmacy Practice Wayne State University August, 2001 Vocabulary Clearance Renal elimination:
More informationDR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA
DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA The good old days The dread (of) infections that used to rage through the whole communities is muted Their retreat
More informationMulticenter Study of In Vitro Susceptibility of the Bacteroides fragilis Group, 1995 to 1996, with Comparison of Resistance Trends from 1990 to 1996
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 1999, p. 2417 2422 Vol. 43, No. 10 0066-4804/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Multicenter Study of In Vitro
More informationMili Rani Saha and Sanya Tahmina Jhora. Department of Microbiology, Sir Salimullah Medical College, Mitford, Dhaka, Bangladesh
Detection of extended spectrum beta-lactamase producing Gram-negative organisms: hospital prevalence and comparison of double disc synergy and E-test methods Mili Rani Saha and Sanya Tahmina Jhora Original
More information2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose
2016 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility
More informationThere are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility
ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Method and guidelines There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility
More informationETX2514: Responding to the global threat of nosocomial multidrug and extremely drug resistant Gram-negative pathogens
ETX2514: Responding to the global threat of nosocomial multidrug and extremely drug resistant Gram-negative pathogens Ruben Tommasi, PhD Chief Scientific Officer ECCMID 2017 April 24, 2017 Vienna, Austria
More information2015 Antimicrobial Susceptibility Report
Gram negative Sepsis Outcome Programme (GNSOP) 2015 Antimicrobial Susceptibility Report Prepared by A/Professor Thomas Gottlieb Concord Hospital Sydney Jan Bell The University of Adelaide Adelaide On behalf
More informationAntibiotics & Resistance
What are antibiotics? Antibiotics & esistance Antibiotics are molecules that stop bacteria from growing or kill them Antibiotics, agents against life - either natural or synthetic chemicals - designed
More informationMoxifloxacin resistance is prevalent among Bacteroides and Prevotella species in Greece
Journal of Antimicrobial Chemotherapy (2008) 62, 137 141 doi:10.1093/jac/dkn134 Advance Access publication 1 April 2008 Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in
More informationEARS Net Report, Quarter
EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased
More informationESCMID Online Lecture Library. by author
EUCAST and susceptibility testing Europe and beyond Gunnar Kahlmeter EUCAST, ESCMID Antimicrobial susceptibility testing To guide therapy and predict clinical outcome in individual patients (clinical breakpoints)
More informationESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL
ESBL- and carbapenemase-producing microorganisms; state of the art Laurent POIREL Medical and Molecular Microbiology Unit Dept of Medicine University of Fribourg Switzerland INSERM U914 «Emerging Resistance
More informationSAMPLE. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals
VET01 5th Edition Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals This standard covers the current recommended methods for disk diffusion
More informationSTAPHYLOCOCCI: KEY AST CHALLENGES
Romney Humphries, PhD D(ABMM) Section Chief, UCLA Clinical Microbiology Los Angeles CA rhumphries@mednet.ucla.edu STAPHYLOCOCCI: KEY AST CHALLENGES THE CHALLENGES detection of penicillin resistance detection
More informationIMPORTANCE OF GLOBAL HARMONIZATION OF ANTIMICROBIAL SUSCEPTIBILITY TESTING IN CANADA FOR DEFINING ANTIMICROBIAL RESISTANCE
IMPORTANCE OF GLOBAL HARMONIZATION OF ANTIMICROBIAL SUSCEPTIBILITY TESTING IN CANADA FOR DEFINING ANTIMICROBIAL RESISTANCE Robert P. Rennie Professor Emeritus Laboratory Medicine and Pathology University
More informationAntibiotic resistance and what can be done
Antibiotic resistance and what can be done A/Professor John Ferguson Microbiologist and Infectious Diseases Physician Pathology NSW Newcastle, NSW, Australia jferguson@hnehealth.nsw.gov.au May 2018 http://idmic.net
More informationINFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER
INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER University of Minnesota Health University of Minnesota Medical Center University of Minnesota Masonic Children s Hospital May 2017 Printed herein are
More informationDr Vivien CHUANG Associate Consultant Infection Control Branch, Centre for Health Protection/ Infectious Disease Control and Training Center,
Dr Vivien CHUANG Associate Consultant Infection Control Branch, Centre for Health Protection/ Infectious Disease Control and Training Center, Hospital Authority NDM-1, which stands for New Delhi Metallo-beta-lactamase-1
More informationAntibiotic resistance a mechanistic overview Neil Woodford
Antibiotic Resistance a Mechanistic verview BSc PhD FRCPath Consultant Clinical Scientist 1 Polymyxin Colistin Daptomycin Mechanisms of antibiotic action Quinolones Mupirocin Nitrofurans Nitroimidazoles
More informationChristiane Gaudreau* and Huguette Gilbert
Journal of Antimicrobial Chemotherapy (1997) 39, 707 712 JAC Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter
More informationMedicinal Chemistry 561P. 2 st hour Examination. May 6, 2013 NAME: KEY. Good Luck!
Medicinal Chemistry 561P 2 st hour Examination May 6, 2013 NAME: KEY Good Luck! 2 MDCH 561P Exam 2 May 6, 2013 Name: KEY Grade: Fill in your scantron with the best choice for the questions below: 1. Which
More informationEDUCATIONAL COMMENTARY CURRENT METHODS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING
Commentary provided by: Linsey Donner, MPH, CPH, MLS (ASCP) CM Assistant Professor, Microbiology and Serology College of Allied Health Professions, Division of Medical Laboratory Science University of
More informationUSA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION
VIRBAC CORPORATION USA Product Label http://www.vetdepot.com P.O. BOX 162059, FORT WORTH, TX, 76161 Telephone: 817-831-5030 Order Desk: 800-338-3659 Fax: 817-831-8327 Website: www.virbacvet.com CLINTABS
More informationMicrobiology. Multi-Drug-Resistant bacteria / MDR: laboratory diagnostics and prevention. Antimicrobial resistance / MDR:
Microbiology Multi-Drug-Resistant bacteria / MDR: laboratory diagnostics and prevention June 2017 MeshHp (VS) Medical Care Center Dr. Eberhard & Partner Dortmund (ÜBAG) www.labmed.de MVZ Dr. Eberhard &
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007
More informationMRSA surveillance 2014: Poultry
Vicky Jasson MRSA surveillance 2014: Poultry 1. Introduction In the framework of the FASFC surveillance, a surveillance of MRSA in poultry has been executed in order to determine the prevalence and diversity
More informationAPPENDIX III - DOUBLE DISK TEST FOR ESBL
Policy # MI\ANTI\04\03\v03 Page 1 of 5 Section: Antimicrobial Susceptibility Testing Manual Subject Title: Appendix III - Double Disk Test for ESBL Issued by: LABORATORY MANAGER Original Date: January
More informationEpidemiology and Antimicrobial Susceptibility of Anaerobic Bloodstream Infections: A 10 Years Study
JMID/ 2018; 8 (4):135-139 Journal of Microbiology and Infectious Diseases doi: 10.5799/xxxxx RESEARCH ARTICLE Epidemiology and Antimicrobial Susceptibility of Anaerobic Bloodstream Infections: A 10 Years
More informationInternational Journal of Pharma and Bio Sciences ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ESBL PRODUCING GRAM NEGATIVE BACILLI ABSTRACT
Research Article Microbiology International Journal of Pharma and Bio Sciences ISSN 0975-6299 ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ESBL PRODUCING GRAM NEGATIVE BACILLI * PRABHAKAR C MAILAPUR, DEEPA
More informationAntibacterial susceptibility testing
Antibiotics: Antil susceptibility testing are natural chemical substances produced by certain groups of microorganisms (fungi, ) that inhibit the growth of or kill the other that cause infection. Several
More information